Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

被引:0
作者
A Tchirkov
J-L Couderc
B Périssel
C Goumy
A Regnier
N Uhrhammer
P Verrelle
M Berger
机构
[1] Centre Jean Perrin,
[2] Service de Cytogénétique Médicale,undefined
[3] CHU – Faculté de Médecine,undefined
[4] UMR 384 INSERM,undefined
[5] Service de Médecine Interne,undefined
[6] CH,undefined
[7] Hématologie,undefined
[8] Faculté de Médecine,undefined
来源
Leukemia | 2006年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 168
页数:1
相关论文
共 28 条
[1]  
Demehri S(2005)e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants? Leukemia 19 681-684
[2]  
Paschka P(1990)P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma Leukemia 4 751-754
[3]  
Schultheis B(1998)MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures Blood 92 2338-2344
[4]  
Lange T(2003)Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program Leukemia 17 2318-2357
[5]  
Koizumi T(2005)Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate Clin Cancer Res 11 3425-3432
[6]  
Sugimoto T(undefined)undefined undefined undefined undefined-undefined
[7]  
Martiat P(undefined)undefined undefined undefined undefined-undefined
[8]  
Mecucci C(undefined)undefined undefined undefined undefined-undefined
[9]  
Nizet Y(undefined)undefined undefined undefined undefined-undefined
[10]  
Stul M(undefined)undefined undefined undefined undefined-undefined